ESC 365 - Severe myocardial dysfunction: a rare side effect of bevacizumab and 5 fluorouracil

HFA Premium Access

Severe myocardial dysfunction: a rare side effect of bevacizumab and 5 fluorouracil

Session: Poster Session 4 - Clinical Cases - Chronic Heart Failure – Pathophysiology and Mechanisms

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Miss P. Mendoza Cuartero (Bilbao, ES)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Miss Paula Maria Mendoza Cuartero

Hospital de Basurto, Bilbao (Spain)

1 presentation

0 follower

4 more presentations in this session

First case of successful treatment with an interatrial shunt device after market authorisation

Speaker: Doctor P. Koeln (Berlin, DE)

Effect of ivabradine on heart rate reduction, change of QRS width and change of LV EF and NT-proBNP in patients with non-ischemic cardiomyopathy and LBBB pattern at baseline

Speaker: Professor F. Malek (Prague, CZ)

The Marfan syndrome case as a successful treatment of severe heart failure.

Speaker: Doctor Y. Martyanova (Astrakhan, RU)

An unexpected cause of acute kidney injury in a patient with ischemic cardiomyopathy treated with sacubitril/valsartan

Speaker: Doctor A. Mortara (Monza, IT)

Access the full session

Poster Session 4 - Clinical Cases - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Miss P. Mendoza Cuartero, Doctor P. Koeln, Professor F. Malek, Doctor Y. Martyanova, Doctor A. Mortara

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources